Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-02

Clinical Trial Update: Tranexamic Acid in Traumatic Brain Injury [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating tranexamic acid for traumatic brain injury is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Assiut University | Conditions: Inflammatory Response | Phase 3 | Status: RECRUITING